Genfit (NASDAQ:GNFT – Get Free Report) and Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, earnings, institutional ownership, risk, analyst recommendations and valuation. Profitability This table compares Genfit and Sorrento Therapeutics’ […]
Financial Analysis: Sorrento Therapeutics (OTCMKTS:SRNEQ) & Protalix BioTherapeutics (NYSE:PLX) kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
A California judge said Thursday he'll grant Sorrento Therapeutics' request to scrap billionaire bioscientist and businessman Dr. Patrick Soon-Shiong's cross-claims over a $90 million transaction involving Sorrento's cancer drug, but allowed leave to amend, noting that since "half of this case went to arbitration," the judge didn't know if the claims were barred by collateral estoppel.
Cabaletta Bio (NASDAQ:CABA – Get Rating) and Sorrento Therapeutics (OTCMKTS:SRNEQ – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends and institutional ownership. Profitability This table compares Cabaletta Bio and Sorrento Therapeutics’ […]